Adicet Bio Inc.

NASDAQ: ACET · Real-Time Price · USD
0.65
0.00 (0.03%)
At close: Aug 15, 2025, 3:59 PM
0.67
2.31%
After-hours: Aug 15, 2025, 07:58 PM EDT

Adicet Bio Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Cash & Equivalents
34.72M 28.13M 56.49M 105.48M 224.07M 247.59M 159.71M 183.26M 205.46M 231.64M 257.66M 282.68M 260.64M 277.88M 277.54M 192.23M 208.73M 221.67M
Short-Term Investments
90.24M 122.31M 119.81M 96.58M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.75M
Long-Term Investments
2.9M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 150K 150K 4.53M 4.53M 4.77M
Other Long-Term Assets
225K 3.22M 3.33M 508K 593K 691K 822K 916K 1M 1.11M 1.21M 1.28M 1.79M 2.01M 2.04M 6.45M 6.53M 6.87M
Receivables
n/a n/a n/a 210K n/a n/a n/a 20K 639K 567K 435K 29K n/a n/a 214K 2.71M 2.71M 2.79M
Inventory
n/a n/a n/a n/a n/a n/a n/a 2.23M 2.07M 2.09M 2.57M -259K n/a n/a -29K 4.09M 4.49M 2.77M
Other Current Assets
93.02M 478K 474K n/a n/a n/a n/a -1.85M 489K 511K 380K 259K n/a n/a 2K 1K 373K 124K
Total Current Assets
127.74M 153.56M 180.14M 206.32M 228.35M 250.35M 162.27M 185.88M 208.66M 234.81M 261.04M 285.74M 264.09M 281.53M 282.44M 199.03M 216.3M 229.11M
Property-Plant & Equipment
32.1M 34.49M 36.75M 39.14M 39.9M 42.05M 44.2M 46.46M 48.51M 49.59M 48.98M 47.82M 44.56M 37.45M 35M 32.26M 26.48M 25.5M
Goodwill & Intangibles
n/a n/a n/a n/a n/a n/a n/a n/a 19.46M 19.46M 19.46M 19.46M 19.46M 19.46M 19.46M 19.46M 19.46M 20.59M
Total Long-Term Assets
35.23M 37.71M 40.08M 39.65M 40.49M 42.74M 45.02M 47.37M 68.98M 70.17M 69.65M 68.57M 65.82M 58.92M 56.5M 58.17M 52.48M 52.97M
Total Assets
162.97M 191.27M 220.22M 245.96M 268.84M 293.1M 207.29M 233.26M 277.63M 304.97M 330.69M 354.3M 329.9M 340.45M 338.94M 257.19M 268.78M 282.07M
Account Payables
3.29M 4.4M 4.83M 2.5M 1.9M 2.54M 2.63M 4.07M 3.12M 2.75M 4.4M 4.57M 4.15M 3.46M 3.26M 4.63M 2.32M 1.75M
Deferred Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 4.8M 10.09M 13.15M 17.96M
Short-Term Debt
2.95M n/a n/a n/a n/a 3.32M 3.22M 3.13M 3.04M n/a 2.49M 2.41M 2.26M 1.73M 1.57M 712K 1.05M 1.25M
Other Current Liabilities
5.88M 4.88M 7.11M 6.1M 7.88M -3.32M 3.71M 3.73M 5.63M n/a 4.62M 3.27M 4.73M 1.16M 2.45M 2.6M 1.77M 937K
Total Current Liabilities
17.08M 16.45M 19.39M 19.39M 17.9M 17.46M 19.29M 19.77M 18.84M 18.09M 19.71M 17.22M 16.4M 10.4M 16.32M 20.03M 20.95M 25.18M
Long-Term Debt
12.4M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Long-Term Liabilities
116K 116K 116K 116K 116K 116K 130K 143K 130K 116K 114K 116K 115K 115K 115K 116K n/a 600K
Total Long-Term Liabilities
12.52M 13.38M 14.22M 15.04M 15.83M 16.83M 17.83M 18.81M 19.73M 20.66M 18.64M 19.42M 20.24M 18.97M 19.49M 19.94M 19.49M 20.63M
Total Liabilities
29.6M 29.82M 33.61M 34.43M 33.73M 34.29M 37.12M 38.58M 38.57M 38.76M 38.35M 36.65M 36.64M 29.37M 35.81M 39.97M 40.44M 45.81M
Total Debt
15.36M 16.25M 17.23M 18.2M 19.13M 20.04M 20.92M 21.8M 22.64M 23.5M 21.02M 21.72M 22.39M 20.58M 20.94M 20.54M 20.54M 21.2M
Common Stock
8K 8K 8K 8K 8K 8K 4K 4K 4K 4K 4K 4K 4K 4K 4K 3K 3K 3K
Retained Earnings
-557.33M -526.11M -497.89M -469.17M -438.69M -408.79M -380.77M -351.28M -301.4M -269M -238.11M -208.24M -186.24M -163.71M -168.32M -152.51M -138.5M -127.64M
Comprehensive Income
-41K -9K 16K 121K n/a n/a n/a n/a n/a -0.00 0.00 n/a -0.00 -0.00 n/a -0.00 n/a 2K
Shareholders Equity
133.37M 161.45M 186.61M 211.53M 235.11M 258.8M 170.18M 194.68M 239.06M -269M -238.11M 317.66M 293.27M 311.08M -168.32M 217.22M 228.34M 236.26M
Total Investments
93.15M 122.31M 119.81M 96.58M n/a n/a n/a n/a n/a n/a n/a n/a n/a 150K 150K 4.53M 4.53M 1.75M